{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Gonadotrophin-releasing+Hormone+%28GnRH%29&page=2", "query": { "condition": "Gonadotrophin-releasing Hormone (GnRH)", "page": 2 }, "page_size": 10 }, "pagination": { "page": 2, "page_size": 10, "total_count": 10, "total_pages": 1, "next_page_url": null, "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Gonadotrophin-releasing+Hormone+%28GnRH%29&page=1&page_size=10" }, "source": "remote", "last_synced_at": "2026-06-10T08:11:51.460Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT01326312", "title": "Effect of GTx-758 on Total and Free Testosterone Levels in Men With Prostate Cancer", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Prostate Cancer" ], "interventions": [ { "name": "GTx-758 1000mg", "type": "DRUG" }, { "name": "Lupron Depot", "type": "DRUG" }, { "name": "GTx-758 2000mg", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "GTx", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "45 Years", "maximum_age": "80 Years", "sex": "MALE", "summary": "45 Years to 80 Years · Male only" }, "enrollment_count": 159, "start_date": "2011-06", "completion_date": "2012-12", "has_results": true, "last_update_posted_date": "2023-06-22", "last_synced_at": "2026-06-10T08:11:51.460Z", "location_count": 36, "location_summary": "Phoenix, Arizona • La Mesa, California • Los Angeles, California + 33 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "La Mesa", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "San Bernardino", "state": "California" }, { "city": "Middlebury", "state": "Connecticut" } ], "official_url": "https://clinicaltrials.gov/study/NCT01326312" }, { "nct_id": "NCT06395753", "title": "A Dose Finding Study of Debio 4228 in Participants With Advanced Prostate Cancer", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Prostate Cancer" ], "interventions": [ { "name": "Debio 4228", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Debiopharm International SA", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "MALE", "summary": "18 Years and older · Male only" }, "enrollment_count": 55, "start_date": "2024-05-23", "completion_date": "2026-07", "has_results": false, "last_update_posted_date": "2026-05-28", "last_synced_at": "2026-06-10T08:11:51.460Z", "location_count": 14, "location_summary": "Mesa, Arizona • Queen Creek, Arizona • Bakersfield, California + 11 more", "locations": [ { "city": "Mesa", "state": "Arizona" }, { "city": "Queen Creek", "state": "Arizona" }, { "city": "Bakersfield", "state": "California" }, { "city": "Chula Vista", "state": "California" }, { "city": "Fresno", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT06395753" }, { "nct_id": "NCT00667446", "title": "Safety Extension Study Of Leuprolide Acetate (Lupron Depot) In The Treatment Of Central Precocious Puberty", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Precocious", "Leuprolide Acetate", "Luteinizing Hormone (LH)", "Gonadotrophin-releasing Hormone Agonist (GnRHa)", "Tanner Staging", "Depot Formulation", "Suppression of LH", "Central Precocious Puberty (CPP)", "Gonadotrophin-releasing Hormone (GnRH)", "Lupron", "GnRH Analog", "Pediatrics Central Precocious Puberty" ], "interventions": [ { "name": "Leuprolide Acetate 3 Month Depot", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "AbbVie (prior sponsor, Abbott)", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "ALL", "summary": "Not listed" }, "enrollment_count": 72, "start_date": "2008-12", "completion_date": "2013-01", "has_results": true, "last_update_posted_date": "2014-01-09", "last_synced_at": "2026-06-10T08:11:51.460Z", "location_count": 16, "location_summary": "Birmingham, Alabama • Long Beach, California • Los Angeles, California + 13 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Long Beach", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "Greenwood Village", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT00667446" }, { "nct_id": "NCT00456274", "title": "Baselines in Reproductive Disorders", "overall_status": "UNKNOWN", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Amenorrhea", "Hypogonadotropic Hypogonadism", "Kallmann's Syndrome" ], "interventions": [ { "name": "Frequent baseline blood sampling", "type": "PROCEDURE" } ], "intervention_types": [ "PROCEDURE" ], "sponsor": "Massachusetts General Hospital", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "16 Years", "maximum_age": "45 Years", "sex": "FEMALE", "summary": "16 Years to 45 Years · Female only" }, "enrollment_count": 180, "start_date": "1999-09", "completion_date": "2020-09", "has_results": false, "last_update_posted_date": "2014-08-04", "last_synced_at": "2026-06-10T08:11:51.460Z", "location_count": 1, "location_summary": "Boston, Massachusetts", "locations": [ { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT00456274" }, { "nct_id": "NCT00004330", "title": "Studies in Porphyria IV: Gonadotropin-Releasing Hormone (GnRH) Analogues for Prevention of Cyclic Attacks", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Porphyria" ], "interventions": [ { "name": "luteinizing hormone-releasing factor", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "National Center for Research Resources (NCRR)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "FEMALE", "summary": "18 Years to 55 Years · Female only" }, "enrollment_count": null, "start_date": "1987-03", "completion_date": null, "has_results": false, "last_update_posted_date": "2005-06-24", "last_synced_at": "2026-06-10T08:11:51.460Z", "location_count": 1, "location_summary": "Galveston, Texas", "locations": [ { "city": "Galveston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT00004330" }, { "nct_id": "NCT01510054", "title": "Endometrial Luteal Phase Characteristics and Luteal Phase Support in Controlled Ovarian Stimulation Protocols With GnRH Antagonists:Focusing on MicroRNA", "overall_status": "WITHDRAWN", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Controlled Ovarian Stimulation" ], "interventions": [], "intervention_types": [], "sponsor": "Johns Hopkins University", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "21 Years", "maximum_age": "31 Years", "sex": "FEMALE", "summary": "21 Years to 31 Years · Female only" }, "enrollment_count": 0, "start_date": "2002-07", "completion_date": "2014-11", "has_results": false, "last_update_posted_date": "2025-07-23", "last_synced_at": "2026-06-10T08:11:51.460Z", "location_count": 1, "location_summary": "Lutherville, Maryland", "locations": [ { "city": "Lutherville", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT01510054" }, { "nct_id": "NCT02663908", "title": "A Trial Comparing Cardiovascular Safety of Degarelix Versus Leuprolide in Patients With Advanced Prostate Cancer and Cardiovascular Disease", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Prostate Cancer" ], "interventions": [ { "name": "Degarelix", "type": "DRUG" }, { "name": "Leuprolide", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Ferring Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "MALE", "summary": "Male only" }, "enrollment_count": 545, "start_date": "2016-04-19", "completion_date": "2021-03-29", "has_results": true, "last_update_posted_date": "2022-06-29", "last_synced_at": "2026-06-10T08:11:51.460Z", "location_count": 48, "location_summary": "Birmingham, Alabama • Tucson, Arizona • Little Rock, Arkansas + 42 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Little Rock", "state": "Arkansas" } ], "official_url": "https://clinicaltrials.gov/study/NCT02663908" }, { "nct_id": "NCT00945477", "title": "Pazopanib as Second Line Therapy in Patients With Metastatic Prostate Cancer Refractory to Total Androgen Blockade", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Prostate Cancer" ], "interventions": [ { "name": "Pazopanib (GW786034)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Illinois CancerCare, P.C.", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "85 Years", "sex": "MALE", "summary": "18 Years to 85 Years · Male only" }, "enrollment_count": 11, "start_date": "2009-07", "completion_date": "2012-10", "has_results": true, "last_update_posted_date": "2013-11-18", "last_synced_at": "2026-06-10T08:11:51.460Z", "location_count": 4, "location_summary": "Bloomington, Illinois • Ottawa, Illinois • Pekin, Illinois + 1 more", "locations": [ { "city": "Bloomington", "state": "Illinois" }, { "city": "Ottawa", "state": "Illinois" }, { "city": "Pekin", "state": "Illinois" }, { "city": "Peoria", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT00945477" }, { "nct_id": "NCT02858336", "title": "CaREFREE Study (Calorie Restriction, Environment and Fitness: Reproductive Effects Evaluation Study)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Hormones" ], "interventions": [ { "name": "NEA", "type": "BEHAVIORAL" }, { "name": "DEA", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "National Institute of Environmental Health Sciences (NIEHS)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "28 Years", "sex": "FEMALE", "summary": "18 Years to 28 Years · Female only" }, "enrollment_count": 38, "start_date": "2017-01-12", "completion_date": "2019-06-29", "has_results": false, "last_update_posted_date": "2026-05-29", "last_synced_at": "2026-06-10T08:11:51.460Z", "location_count": 1, "location_summary": "Research Triangle Park, North Carolina", "locations": [ { "city": "Research Triangle Park", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT02858336" }, { "nct_id": "NCT00826839", "title": "Oral Microdose Lupron Versus Luteal Estradiol Trial in Poor Responder In Vitro Fertilization (IVF) Patients", "overall_status": "WITHDRAWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Infertility" ], "interventions": [ { "name": "Oral contraceptive pill and microdose lupron", "type": "DRUG" }, { "name": "E2 patch/antagonist", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Weill Medical College of Cornell University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "50 Years", "sex": "FEMALE", "summary": "18 Years to 50 Years · Female only" }, "enrollment_count": 0, "start_date": "2009-01", "completion_date": "2012-01", "has_results": false, "last_update_posted_date": "2013-06-25", "last_synced_at": "2026-06-10T08:11:51.460Z", "location_count": 1, "location_summary": "New York, New York", "locations": [ { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT00826839" } ] }